Economy · Full coverage
Pozis Family Boosts Stake and Overhauls Novolog Board to Block Movement Group Takeover
How 2 Israeli newsrooms covered this story — translated into English and compared side by side.
Unrated 2
First reported by Calcalist · Aug 5, 2026
What happened
The Pozis family increased its stake in Novolog to 44.9% and replaced the board to prevent a takeover by the Movement Group, appointing Oded Pozis as chairman.
- 01Pozis family raised Novolog stake from 26.7% to 44.9% by buying 18.2% shares for 91 million shekels.
- 02Oded Pozis appointed chairman, replacing Eric Shor who resigned.
- 03Three new directors joined, replacing two who resigned, aligning the board with Pozis interests.
- 04Movement Group proposed a 100 million shekel investment for shares, triggering Pozis opposition.
- 05Pozis family sent a legal warning and vowed to fight the takeover attempt.
- 06External directors Ruth Relevag and Itzik Edelman remain on the board for now.
Summary translated & synthesized from the sources below by baba. Read each original for the full report.
Full coverage · 2 outlets
The same event, reported separately by each newsroom. Open a few to compare what each emphasizes — and what they leave out.
CalcalistUnrated · HebrewAug 6, 2026
Pozis Family Boosts Stake and Overhauls Novolog Board to Block Movement Group Takeover
GlobesUnrated · HebrewAug 6, 2026
Oded Pozis Takes Control of Novolog, Appoints New Board Amid Ownership Battle
Related stories
Pozis Family Vows Legal Fight and Possible Stake Increase in Novolog Control BattleJul 30, 2026Control Battle Erupts at Israeli Healthcare Firm Novolog Over Major Investment OfferAug 2, 2026Novolog Control Battle Intensifies as Owner Seeks Board Dissolution Amid Movement's Buyout OfferJul 30, 2026Pazis Family Secures Control of Israeli Pharma Distributor Novolog After Boardroom Battle3 days agoLeon Rekanti Acquires 6.5% Stake in Struggling Biomed Company Avogen Amid Control BattleAug 9, 2026New Investors Seek Board Overhaul in Biomed Firm Evogene Amid Sharp Share DeclineJul 22, 2026